Cambridge, MA, United States of America

Joachim Theilhaber

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Sanofi, Aventis Pharmaceuticals Inc.. Active years: 2002-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joachim Theilhaber. Retrieved from https://idiyas.com/inventor/joachim-theilhaber

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.1

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2002-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Joachim Theilhaber

Introduction

Joachim Theilhaber is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of biotechnology. He holds a total of four patents, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Among his latest inventions are the anti-TGF-beta antibodies and their use. This invention provides an improved pan-TGF-β antibody for the treatment of conditions mediated by TGF-β, including autoimmune diseases, fibrotic conditions, and cancers. Additionally, the invention outlines methods and uses of the antibody in conjunction with other immunomodulatory agents, such as an anti-PD-1 antibody.

Career Highlights

Throughout his career, Joachim Theilhaber has worked with prominent companies in the pharmaceutical industry, including Sanofi and Aventis Pharmaceuticals Inc. His work has focused on developing innovative solutions to complex medical challenges.

Collaborations

Some of his notable coworkers include Gary Shapiro and Kevin Brower, who have contributed to his research and development efforts.

Conclusion

Joachim Theilhaber exemplifies the spirit of innovation in biotechnology through his patents and collaborations. His work continues to impact the medical field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…